Adenosine A3 Receptor Antikörper (AA 195-244)
-
- Target Alle Adenosine A3 Receptor (ADORA3) Antikörper anzeigen
- Adenosine A3 Receptor (ADORA3)
-
Bindungsspezifität
- AA 195-244
-
Reaktivität
- Human, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Adenosine A3 Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human ADORA3
- Homologie
- Percent identity by BLAST analysis: Human (100%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa195-244 of human ADORA3 (Q5QNY7, NP_001075445). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset (100%), Galago, Elephant, Bovine, Horse (92%), Panda, Bat (84%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product ADORA3 Primärantikörper
-
-
- Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- Adenosine A3 Receptor (ADORA3)
- Andere Bezeichnung
- ADORA3 / Adenosine A3 Receptor (ADORA3 Produkte)
- Hintergrund
-
Name/Gene ID: ADORA3
Subfamily: Adenosine
Family: GPCR
Synonyms: ADORA3, A3AR, AD026, Adenosine A3 receptor, BA552M11.5, A3 adenosine receptor, Adenosine receptor A3, RP11-552M11.7 - Gen-ID
- 140
- NCBI Accession
- NP_001075445
- UniProt
- P33765
- Pathways
- Hormone Transport, cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-